Symbol="KROS"
AssetType="Common Stock"
Name="Keros TherapeuticsÂ Inc"
Description="Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with a great unmet medical need. The company is headquartered in Lexington, Massachusetts."
CIK="1664710"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="99 HAYDEN AVENUE, SUITE 120 (BLD E), LEDGEMONT TECHNOLOGY CENTER, LEXINGTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1028347000"
EBITDA="-139531008"
PERatio="None"
PEGRatio="None"
BookValue="11"
DividendPerShare="0"
DividendYield="0"
EPS="-4.43"
RevenuePerShareTTM="0.824"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.3"
ReturnOnEquityTTM="-0.471"
RevenueTTM="20000000"
GrossProfitTTM="-87265000"
DilutedEPSTTM="-4.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="90.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="68.42"
PriceToBookRatio="5.74"
EVToRevenue="57.24"
EVToEBITDA="-14.45"
Beta="1.083"
num_52WeekHigh="59.96"
num_52WeekLow="33.11"
num_50DayMovingAverage="40.78"
num_200DayMovingAverage="46.26"
SharesOutstanding="29584200"
DividendDate="None"
ExDividendDate="None"
symbol="KROS"
open="34.58"
high="35.09"
low="33.27"
price="33.30"
volume="179886.00"
latest_trading_day="2023-08-16"
previous_close="34.76"
change="-1.46"
change_percent="-4.2002%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="200730"
Change_recent_avg="-0.08"
Delta_recent_avg="2.09"
Variance_recent_avg="1.04"
Change_ratio_recent_avg="-0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="517"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_negative_thumbnail_id_2="501"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0104.jpeg"
image_neutral_thumbnail_id_1="596"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="648"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_positive_thumbnail_id_2="653"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
